Results 81 to 90 of about 114,759,215 (188)
Portal Hypertension &Cirrhosis, EarlyView.This preclinical study evaluated a novel controlled‐expansion expanded polytetrafluoroethylene (ePTFE)‐covered transjugular intrahepatic portosystemic shunt (TIPS) stent in 11 swine, demonstrating 100% technical success, excellent deployability, and durable 6‐month angiographic patency without thrombosis, migration, fracture, or device‐related toxicity.
Yi Xiang +15 more
wiley +1 more source
Finite element and mechanobiological modelling of vascular devices [PDF]
, 2011 There are two main surgical treatments for vascular diseases, (i) percutaneous stent deployment and (ii) replacement of an atherosclerotic artery with a vascular graft or tissue engineered blood vessel.
Zahedmanesh, Houman
core +2 more sources
The application and efficacy of stent place for Budd-Chiari syndrome
Journal of Interventional Medicine, 2018 : Objective To evaluate the application value and efficacy on stent place for Budd-Chiari syndrome (BCS).Methods From January 1990 to May 2017, 2228 patients with BCS were admitted to our institution. The mean age was 43.3 years.
Maoheng Zu +6 more
doaj +1 more source
Small, EarlyView.A multifunctional 3D‐printed polymer–ZrO2 scaffold is developed to provide intrinsic radiopacity, photothermal responsiveness, and surface bioactivity. Reinforcement with ZrO2 enables real‐time x‐ray visibility and mechanical robustness, while a polydopamine coating facilitates near‐infrared‐triggered drug release and modulates cell migration, thereby ...
Sumin Kang +10 more
wiley +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala +13 more
wiley +1 more source
Recurrence of Subacute Stent Thrombosis and In-Stent Restenosis during Five Months after Stent Implantation in the LAD. A Case Report. [PDF]
, 2001 A coronary stent was deployed in the left anterior descending artery of an 82-year-old woman with unstable angina.Recurrence of subacute stent thrombosis and in-stent restenosis occurred frequently during the five months after initial stent implantation ...
島田, 弘英 +4 more
core
Revista Portuguesa de Cardiologia, 2019 Introduction: Stent restenosis remains a clinical challenge for patients with ischemic heart disease, since it is associated with repeated coronary interventions as well as higher hospitalization rates and medical costs.
Ibrahim Rencuzogullari +9 more
doaj +1 more source
Journal of Diabetes Investigation, EarlyView.Among patients with type 2 diabetes undergoing percutaneous coronary intervention, thiazolidinedione use was independently associated with a significantly reduced risk of a composite of myocardial infarction, stroke, and all‐cause death, notably without an increased risk of admission for heart failure. ABSTRACT Background Thiazolidinediones (TZD) are a
Jinkwon Kim +5 more
wiley +1 more source
Review: Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?
, 2008 Restenosis is an important limitation of percutaneous coronary interventions (PCI). In-stent restenosis is mainly due to neointimal hyperplasia, a proliferative process modulated by inflammatory mechanisms.
Galeote, Guillermo +7 more
core +1 more source
Annals of Noninvasive Electrocardiology, Volume 31, Issue 6, November 2026.The Spiked Helmet Sign on electrocardiogram after LVAD implantation serves as a critical early warning of localized pericardial hematoma and impending tamponade. Prompt recognition should trigger immediate echocardiographic evaluation, as demonstrated in this case, to guide urgent management.
Qin Qian, Ling Yin
wiley +1 more source